Synthesis and biodistribution of Bowman-Birk soybean protease inhibitor conjugate with amphiphilic polyester

Applied Biochemistry and Biotechnology - Part A Enzyme Engineering and Biotechnology

Volumn 61, Issue 1-2, 1996, Pages 139-148

  Larionova, Natalia I ^a   Gladysheva, Inna P ^a   Polekhina, Olga V ^b   Kurochkina, Lidiya P ^a   Gorbatova, Elena N ^b  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

^b STATE RESEARCH INSTITUTE OF ORGANIC CHEMISTRY AND TECHNOLOGY   (Russian Federation)

Author keywords

Conjugate; Mice; Pharmacokinetics; Physiological model; Soybean Bowman Birk protease inhibitor

Indexed keywords

BOWMAN BIRK INHIBITOR; EPOXIDE; ETHYLENE OXIDE; POLYESTER; POLYMER; PROPYLENE OXIDE; SURFACTANT;

ANIMAL; ARTICLE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MACROMOLECULE; MALE; MOUSE; SYNTHESIS; TISSUE DISTRIBUTION;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EPOXY COMPOUNDS; ETHYLENE OXIDE; MACROMOLECULAR SUBSTANCES; MALE; MICE; POLYESTERS; POLYMERS; SURFACE-ACTIVE AGENTS; TISSUE DISTRIBUTION; TRYPSIN INHIBITOR, BOWMAN-BIRK SOYBEAN;

EID: 0030256015     PISSN: 02732289     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02785696     Document Type: Article

References (25)

1. Kennedy, A. R. (1993), in Protease Inhibitors as Cancer Chemoprevenlive Agents, Troll, W. and Kennedy, A. R., eds., Plenum, New York, pp. 9-64.
2. Kennedy, A. R. (1993), in Protease Inhibitors as Cancer Chemopreventive Agents, Troll, W. and Kennedy, A. R., eds., Plenum, New York, pp. 65-91.
3. Persiani, S., Yeung, A., Shen, W. C., and Kennedy, A. R. (1991), Carcinogenesis 12, 1149-1152.
4. Chang, T. M. S. (1977), Biomedical Application of Immobilized Enzymes and Proteins. Plenum, New York.
5. Madar, Z., Gertler, A., and Birk, Y. (1979), Comp. Biochem. Physiol. 62A, 1057-1061.
6. Billings, P. C., St. Clair, W. H., Maki, P. A., and Kennedy, A. R. (1992), Cancer Lett. 62, 191-197.
7. Kirillova, G. P., Mochova, E. M., Deduchova, V. I., Tarakanova, A. N., Ivanova, V. P., Efremova, N. V., and Topchieva, I. N. (1993), Biotechnol. Appl. Biochem. 18, 329-339.
8. King, F. G. and Dedrick, R. L. (1979), Cancer Treatment Rep. 63, 1939-1947.
9. Chen, H.-S. and Gross, J. F. (1979), Cancer Chemother. Pharmacol. 2, 85-94.
10. Larionova, N. I., Gladysheva, I. P., Tikhonova, T. V., and Kazanskaya, N. F. (1993), Biochemistry (Moscow) 58, 1046-1052.
11. Boccu, E., Largajolly, R., and Veronese, F. M. (1983), Naturforschung 3, 94-99.
12. Bradford, M. M. (1976), Anal. Biochem. 181, 321-330.
13. McConahey, P. C. and Dixon, F. J. (1980), Methods Enzymol. 70, 221-247.
14. Kong, A.-Ng. and Jusko, W. (1988), J. Pharm. Sci. 77, 157-165.
15. Hatanaka, T., Sato, S., Endo, H. M., Katayama, K., Kakemi, M., and Koizumi, T. (1988), J. Parmacobio-Dyn. 11, 18-30.
16. Sato, H., Okezaki, E., and Yamamoto, S. (1988), J. Pharmacobio-Dyn. 11, 386-394.
17. Ritschel, W. A. and Banerjee, P. S. (1986), Methods and Findings Expl. Clin. Pharmacol. 8, 603-614.
18. Gerlowski, L. and Jain, R. (1983), J. Pharm. Sci. 72, 1103-1127.
19. Ratkowski, D. A. (1983), Nonlinear Regression Modeling, Marcel Dekker, New York.
20. King, F. G., Dedrick, R. L., Collins, J. M., Mattews, H. B., and Birnbaum, L. S. (1983), Toxicol. Appl. Pharmacol. 67, 390-400.
21. Yavelow, J., Collins, M., Birk, Y., Troll, W., and Kennedy, A. R. (1985), Proc. Natl. Acad. Sci. USA 82, 5395-5399.
22. Odani, S. and Ikenaka, T. (1972), J. Biochem. 71, 839-848.
23. Fields, R. (1971), Biochem. J. 124, 581-590.
24. Lowry, O. H., Rosebrough, N. S., Farr, A. L., and Randall, R. J. (1951), J. Biol. Chem. 193, 265-275.
25. Larionova, N. I., Topchieva, I. N., Gladysheva, I. P., and Kennedy, A. R. (1994), Cancer J. 7, 158-163.